X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ALKEM LABORATORIES - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ALKEM LABORATORIES ALEMBIC LTD/
ALKEM LABORATORIES
 
P/E (TTM) x 50.2 - - View Chart
P/BV x 2.1 6.6 32.4% View Chart
Dividend Yield % 0.5 0.7 72.6%  

Financials

 ALEMBIC LTD   ALKEM LABORATORIES
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
ALKEM LABORATORIES
Mar-16
ALEMBIC LTD/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs721,589 4.5%   
Low Rs341,232 2.8%   
Sales per share (Unadj.) Rs4.7417.5 1.1%  
Earnings per share (Unadj.) Rs6.156.3 10.8%  
Cash flow per share (Unadj.) Rs6.264.7 9.7%  
Dividends per share (Unadj.) Rs0.2012.70 1.6%  
Dividend yield (eoy) %0.40.9 42.0%  
Book value per share (Unadj.) Rs40.7292.9 13.9%  
Shares outstanding (eoy) m267.03119.57 223.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.33.4 333.4%   
Avg P/E ratio x8.725.1 34.6%  
P/CF ratio (eoy) x8.521.8 38.9%  
Price / Book Value ratio x1.34.8 27.0%  
Dividend payout %3.322.6 14.5%   
Avg Mkt Cap Rs m14,139168,653 8.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2079,171 2.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,25549,915 2.5%  
Other income Rs m3701,645 22.5%   
Total revenues Rs m1,62551,561 3.2%   
Gross profit Rs m1118,482 1.3%  
Depreciation Rs m381,006 3.8%   
Interest Rs m2671 0.3%   
Profit before tax Rs m4428,451 5.2%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m241,606 1.5%   
Profit after tax Rs m1,6306,731 24.2%  
Gross profit margin %8.917.0 52.1%  
Effective tax rate %5.419.0 28.5%   
Net profit margin %129.813.5 962.9%  
BALANCE SHEET DATA
Current assets Rs m1,86727,062 6.9%   
Current liabilities Rs m59115,324 3.9%   
Net working cap to sales %101.623.5 432.3%  
Current ratio x3.21.8 178.8%  
Inventory Days Days9467 141.7%  
Debtors Days Days7441 178.2%  
Net fixed assets Rs m1,79112,610 14.2%   
Share capital Rs m534239 223.4%   
"Free" reserves Rs m10,32434,490 29.9%   
Net worth Rs m10,85835,027 31.0%   
Long term debt Rs m411,212 3.4%   
Total assets Rs m11,59154,387 21.3%  
Interest coverage x260.913.6 1,917.9%   
Debt to equity ratio x00 11.0%  
Sales to assets ratio x0.10.9 11.8%   
Return on assets %14.113.6 103.4%  
Return on equity %15.019.2 78.1%  
Return on capital %15.224.9 61.1%  
Exports to sales %1.512.9 11.9%   
Imports to sales %21.03.1 679.9%   
Exports (fob) Rs m196,461 0.3%   
Imports (cif) Rs m2631,540 17.1%   
Fx inflow Rs m196,563 0.3%   
Fx outflow Rs m2643,012 8.8%   
Net fx Rs m-2443,552 -6.9%   
CASH FLOW
From Operations Rs m2367,259 3.2%  
From Investments Rs m-2241,864 -12.0%  
From Financial Activity Rs m-27-9,273 0.3%  
Net Cashflow Rs m-15-150 9.9%  

Share Holding

Indian Promoters % 64.0 66.9 95.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 33.1 0.6%  
FIIs % 9.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 0.0 -  
Shareholders   54,701 68,381 80.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   TORRENT PHARMA  ALEMBIC PHARMA  AJANTA PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare ALEMBIC LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 118 Points Higher; Realty and Banking Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours of trade and ended the day marginally higher.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Nov 15, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - MERCK LTD COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS